Variations in glucose/C-peptide ratio in patients with type 2 diabetes associated with renal function

Diabetes Research and Clinical Practice
John A D'EliaLarry A Weinrauch

Abstract

Accurate dosing of medications for glycemic control is a challenge for clinicians in diabetic patients with kidney disease. Diminishing glomerular filtration rates are associated with decreased renal clearance of insulin and increased prevalence of hypoglycemic episodes. Measurement of glucose/C peptide ratios may be useful to guide dosing in those patients who receive powerful insulin secretogogues as glomerular function decreases with age and disease. In order to determine the relationship between glucose, C-peptide and renal function, we reviewed the records of patients with type 2 diabetes followed in our kidney hypertension clinic who met the following criteria: age 35-90 years, requirement of medications to control glycemia, at least 4 simultaneous measurements of C peptide, HbA1c, creatinine and blood glucose. 87 patients (67 males, 20 females), ages 67.1 ± 10.6 years, BMI 32.5 ± 5.2, A1c 8.2 ± 1.2%, eGFR 73 ± 27.2 ml/min, had glucose/C-peptide ratios 60.7 ± 46.4. 59% of the total group were taking insulin secretogogues. Patients were divided into groups based upon mean eGFR and use or absence of insulin secretogogues. Glucose C-peptide ratios were lowest in the quartile of patients with the lowest eGFR (<50 ml/min). Dim...Continue Reading

References

Feb 1, 1979·The American Journal of Cardiology·J A D'EliaO S Leland
Jan 1, 1977·Annals of Internal Medicine·L A WeinrauchJ A D'Elia
Oct 1, 1977·The Journal of Clinical Investigation·T J ReganB Haider
Jan 1, 1992·Nephron·R H Mak, R A DeFronzo
Sep 1, 1987·The Journal of Clinical Endocrinology and Metabolism·I ZavaroniA Gnudi
Nov 8, 1972·The American Journal of Cardiology·S RublerA Grishman
Jan 1, 1982·Clinical and Experimental Dialysis and Apheresis·J A D'EliaL A Weinrauch
May 1, 1982·The American Journal of Medicine·J A D'EliaL A Weinrauch
Aug 1, 1996·Pediatric Research·R H Mak
Jan 1, 1986·The Korean Journal of Internal Medicine·R S KimY K Choi
Jun 10, 2008·The New England Journal of Medicine·UNKNOWN Action to Control Cardiovascular Risk in Diabetes Study GroupWilliam T Friedewald
Apr 1, 2009·The American Journal of Medicine·Medha N MunshiDarlene Ayres
Feb 19, 2013·Diabetic Medicine : a Journal of the British Diabetic Association·A G Jones, A T Hattersley
May 7, 2014·Archives of Cardiovascular Diseases·Elisabeth CoupezPascal Motreff
Jan 18, 2018·Clinical Journal of the American Society of Nephrology : CJASN·Katherine G GarloDavid M Charytan
Mar 15, 2018·The New England Journal of Medicine·Joseph LoscalzoJames R Stone

❮ Previous
Next ❯

Citations

Apr 4, 2020·Progress in Transplantation : Official Publication, North American Transplant Coordinators Organization ... [et Al.]·Julia TorabiJay A Graham

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.